Pregnancy and Birth

United States labor induction rates have expanded to 37 and 38 weeks despite a lack of randomized evidence supporting non–medically indicated induction before 39 weeks.

A new AHA scientific statement outlines how earlier prevention, rapid diagnosis and timely treatment can reduce the risks of maternal stroke during pregnancy and postpartum.

The AAP'S 2026 schedule has been endorsed by 12 medical and health organizations, including the American College of Nurse Midwives and the American College of Obstetricians and Gynecologists.

In patients with diet-controlled gestational diabetes, continuing pregnancy beyond 39 weeks was associated with increasing maternal and neonatal risks.

A large cohort study found that prenatal exposure to acid-suppressive medications was not associated with neuropsychiatric disorders in children.

Early postpartum blood pressure self-monitoring with physician-guided medication adjustment was linked to sustained reductions in blood pressure among women with hypertensive pregnancies.

A nationwide Norwegian cohort study suggests that prenatal factors, including fetal growth and maternal diabetes, may influence the risk of developing multiple sclerosis in adulthood.

A phase 3 trial of oral brexanolone for postpartum depression will continue unchanged following a favorable DSMB safety review.

A population-based study links minimum wage increases to improved maternal cardiovascular health during pregnancy.

Ashley Michnick, PharmD, PhD, explained that early findings support RSVpreF pregnancy safety, while emphasizing the need for continued monitoring.

ACOG's 2025 clinical consensus recommends universal screening for cannabis use before, during, and after pregnancy and advises that there are no medical indications for cannabis use during pregnancy and the postpartum period.

A large California cohort study shows that aggregating Asian American and Pacific Islander populations can obscure substantial differences in hypertensive disorder risk during pregnancy.

Analysis of internal FDA records reveals that mifepristone’s REMS program was shaped by repeated evidence-based safety reviews.

Maternal influenza and Tdap vaccination during pregnancy was associated with fewer influenza- and pertussis-related hospital and ED visits in infants younger than 6 months.

Screen-guided care using the PreTRM blood test reduced preterm birth–related complications and NICU use.

New research links abnormal collagen remodeling at cesarean scars—not placental invasion—to placenta accreta spectrum risk.

A study links opioid-related diagnoses during pregnancy to increased maternal morbidity and neonatal complications.

A randomized trial found that real-time continuous glucose monitoring reduced large-for-gestational-age births compared with self-monitoring in gestational diabetes.

Higher maternal vitamin D levels in pregnancy were associated with reduced odds of early childhood caries and lower DMFT scores in offspring.

A new study reveals 3 NAD-related metabolites elevated in women with recurrent miscarriage, indicating potential risk identification.

Discontinuing GLP-1 receptor agonists before or early in pregnancy was associated with greater gestational weight gain and higher risks of diabetes, hypertension, and preterm birth.

New data highlight how optical genome mapping can uncover chromosomal abnormalities missed by traditional tests.

A review reported insufficient evidence connecting prenatal paracetamol exposure to autism or ADHD.

Holiday meals carry extra food safety risks for pregnant patients. Here’s what ob-gyns should remind them before Thanksgiving gatherings.

Planned community births in Oregon showed increased risks only when hospital transfer occurred, underscoring the need for clear counseling and transfer systems.